HeartBeam (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation

Questions around this news

What is the HeartBeam–Mount Sinai collaboration intended to do?
The collaboration is intended to develop and validate artificial intelligence-based electrocardiogram (ECG) algorithms. The release says the algorithms are intended for broad deployment across HeartBeam’s platform, as the company expands its work on AI-enabled cardiac monitoring.
What applications could the AI-ECG algorithms support?
The release describes potential wellness and clinical applications, including personalized insights and assessing heart attack risk. It does not provide further details about specific algorithms, how they would be used in care, or when they might become available.
What role does Mount Sinai have in the project?
Mount Sinai is collaborating with HeartBeam on developing and validating AI-based ECG algorithms. The announcement identifies the organizations’ shared work but does not specify Mount Sinai’s particular responsibilities, the project’s timeline, or how validation will be conducted.

The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate AI-based ECG Algorithms
The collaboration is focused on building next-generation, personalized AI-ECG algorithms for wellness and clinical applications, including assessing heart attack risk
HeartBeam’s role in this evolving landscape is anchored by its HeartBeam System

HeartBeam (NASDAQ: BEAT) recently announced a collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology, marking another step in the company’s push to expand its role in next-generation cardiac monitoring. The announcement highlights HeartBeam’s growing focus on artificial intelligence (“AI”)-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward data-driven, remote monitoring solutions.

The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate high value, AI-based ECG algorithms that can be deployed broadly across HeartBeam’s platform. These AI models may include patient-relevant wellness insights, condition-focused…

Terms explained

ECG: An electrocardiogram is a recording of the heart’s electrical activity, typically captured using electrodes placed on the body.
Artificial intelligence (AI): A broad term for computer systems designed to perform tasks that commonly require human-like capabilities, such as recognizing patterns in data.
Algorithm: A defined set of computational steps used to process information or solve a problem. In healthcare, algorithms may analyze patient data to identify patterns.
Validation: The process of evaluating whether a method or system performs as intended for its specified purpose, using appropriate evidence or testing.

SEC filings

Earlier from HeartBeam

Back to News Center

HeartBeam (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation

Questions around this news

What is the HeartBeam–Mount Sinai collaboration intended to do?

What applications could the AI-ECG algorithms support?

What role does Mount Sinai have in the project?

Terms explained

SEC filings

Earlier from HeartBeam